Loading provider…
Loading provider…
Hematology & Oncology Physician in San Diego, CA
NPI: 1265408678Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get M.D. Teresa's Phone NumberMobile
Get M.D. Teresa's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2000 - 2026

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
University of California (San Diego) Medical Center
Fellowship • Hematology and Medical Oncology
2002 - 2005
Los Angeles County-Harbor-UCLA Medical Center
Residency • Internal Medicine
1998 - 2002
UC Davis School of Medicine
health.ucdavis.edu
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 103 | 159 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 45 | 93 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
Authors: Howard Burris, Muralidhar Beeram, Kevin Kalinsky, Brent Rexer, Alison Conlin, Komal Jhaveri, J Beck, Sara Tolaney, Elizabeth Dees
Journal: Front Oncol
Publication Date: 2022-02-10
Authors: Muralidhar Beeram, Alison Conlin, Komal Jhaveri, Sara Tolaney, Elizabeth Dees
Journal: Front Oncol
Publication Date: 2025-03-12
Lead Sponsor: Teresa Helsten, MD
Collaborators: Clovis Oncology, Inc.
Intervention / Treatment: DRUG: Lucitanib
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Letrozole, DRUG: BYL719, DRUG: LEE011
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Fulvestrant, DRUG: Dovitinib, DRUG: Dovitinib Placebo